Cancer Drugs and Vaccines

Current research focuses on the effectiveness of in-situ vaccines in multiple types of cancer. Recent trial has also confirmed the effectiveness of cancer vaccine VBI-1901 in the treatment of glioblastoma.

In 2019, FDA has approved more than 10 drugs for the treatment of cancers, few of which are:

  • Balversa (erdafitinib)- Urothelial carcinoma
  • Polivy (polatuzumab vedotin-piiq)- Diffuse large B-cell lymphoma
  • Xpovio (selinexor)- Relapsed or refractory multiple myeloma
  • Venclexta (venetoclax) plus Gazyva (obinutuzumab)- Chronic lymphocytic leukemia
  • Piqray (alpelisib)- HR+, HER2-negative, PIK3CA-mutated advanced or metastatic breast cancer

Many new cancer drugs like Nivolumab, Bortezomib, Erlotinib, Abiraterone, Arsenic, Pegaspargase, etc and cancer diagnostic tests, where, in 2019, 12 tests which are used to detect a wide range of solid tumors, including colorectal, liver, cervical, prostate, breast, and germ cell cancers, as well as leukemia and lymphomas have been added to the WHO's lists of essential medicines and essential diagnostic tests.

Related Conference of Oncology & Cancer